The 3′ untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation

By Jakubowska Anna   Gronwald Jacek   Górski Bohdan   Huzarski Tomasz   Byrski Tomasz   Benner Axel   Lubiński Jan   Scott Rodney J.   Hamann Ute  

Breast Cancer Research and Treatment, Vol. 104, Iss. 1, 2007-07 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

The VDR gene FokI polymorphism and ovarian cancer risk

By Xu Hui   Li Su   Qiu Jian-Qing   Gao Xiao-Lin   Zhang Ping   Yang Yong-Xia  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3309-3316

Springer Publishing Company

Access to resources Recommend Favorite

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers

By Jakubowska Anna   Rozkrut Dominik   Antoniou Antonis   Hamann Ute   Lubinski Jan  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 639-649

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Postmenopausal estrogen monotherapy–associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism

By  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 295-295

Springer Publishing Company

Access to resources Recommend Favorite

Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters

By Blokhuis M.   Pietersen G.   Goldberg P.   Algar U.   Merwe L.   Mbatani N.   Vorster A.   Ramesar R.  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 357-363

Springer Publishing Company

Access to resources Recommend Favorite